# D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder

> **NCT00842309** · EARLY_PHASE1 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 68 (actual)

## Conditions studied

- Body Dysmorphic Disorder

## Interventions

- **DRUG:** d-cycloserine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00842309
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2017-12
- **Final completion:** 2018-08
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2019-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00842309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00842309, "D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00842309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*